Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
2019-04 Achaogen files for bankruptcy
Parent topics
Antibiotic resistance and pharmaceutical business models
This topic
Recent activity
You must be
signed in
to add and move topics and links.
'Post-antibiotics' world is here, experts say
https://www.modernhealthcare.com/safety-quality/post-antibiotics-world-here-experts-say
2019-04 Achaogen files for bankruptcy
2019-04 UN IACG report on antimicrobial resistance
'Startling' lack of progress in fight against superbugs, report warns
https://www.telegraph.co.uk/global-health/science-and-disease/startling-lack-progress-fight-against-superbugs-report-warns/
2019-04 Achaogen files for bankruptcy
Antimicrobial resistance in the United Kingdom
Jim O'Neill
Achaogen sells remaining assets
https://www.in-pharmatechnologist.com/Article/2019/06/10/Achaogen-sells-remaining-assets
2019-04 Achaogen files for bankruptcy
Achaogen-Canary in the Coal Mine or Developer of an Unwanted Product?
https://www.contagionlive.com/publications/contagion/2019/june/achaogen-canary-in-the-coal-mine-or-developer-of-an-unwanted-product
2019-04 Achaogen files for bankruptcy
Carbapenem-resistant Enterobacteriaceae (CRE)
Plazomicin
Aligning Payment And Prevention To Drive Antibiotic Innovation For Medicare Beneficiaries
https://www.healthaffairs.org/do/10.1377/hblog20190802.505113/full/
2019-04 Achaogen files for bankruptcy
2019-08 Centers for Medicaid & Medicare Services announcement about changes to antibiotic reimbursements
Plazomicin
Antibiotic developer Melinta files for bankruptcy | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/12/antibiotic-developer-melinta-files-bankruptcy
2019-04 Achaogen files for bankruptcy
2019-12 Melinta files for bankruptcy
Antibiotic resistance and pharmaceutical business models
DISARM Act model legislation
Delafloxacin
Plazomicin
Antibiotics Aren’t Profitable Enough for Big Pharma to Make More
https://www.bloomberg.com/news/articles/2019-05-03/antibiotics-aren-t-profitable-enough-for-big-pharma-to-make-more
2019-04 Achaogen files for bankruptcy
Carbapenem-resistant Enterobacteriaceae (CRE)
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Antibiotics Developers Seek a Cure for Industry Ills - WSJ
https://www.wsj.com/articles/antibiotics-developers-seek-a-cure-for-industry-ills-11563465704
2019-04 Achaogen files for bankruptcy
As Threat of Antibiotic Resistance Mounts, Biotechs Are Running Out of Cash and Time
https://morningconsult.com/2019/09/05/as-threat-of-antibiotic-resistance-mounts-biotechs-are-running-out-of-cash-and-time/
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
DISARM Act model legislation
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Working to Fight AMR
BEVA weighs in with antimicrobial resistance guidance | Vet Times
https://www.vettimes.co.uk/news/beva-weighs-in-with-antimicrobial-resistance-guidance/
2019-04 Achaogen files for bankruptcy
Events focusing on antibiotics
Biotech Firms Fight Panic Over Spread of Superbugs | Fast Forward | OZY
https://www.ozy.com/fast-forward/biotech-firms-fight-panic-over-spread-of-superbugs/96609
2019-04 Achaogen files for bankruptcy
2019-07 NHS to pilot a subscription approach to promote the development of new antibiotics
Antibiotic resistance and pharmaceutical business models
Broad-spectrum antibiotics
CARB-X
Human gut microbiome
Ridinilazole
Building New Models To Support The Ailing Antibiotics Market
https://www.forbes.com/sites/thelabbench/2019/05/10/building-new-models-to-support-the-ailing-antibiotics-market/
2019-04 Achaogen files for bankruptcy
CARB-X partnership pushes development of new antibiotics
https://www.apnews.com/8f83732715074750b36bee156f905e1a
2019-04 Achaogen files for bankruptcy
CARB-X partnership pushes development of new antibiotics - StamfordAdvocate
https://www.stamfordadvocate.com/business/article/CARB-X-partnership-pushes-development-of-new-14191386.php
2019-04 Achaogen files for bankruptcy
CARB-X
Commentary: How COVID-19 has added to the problem of drug-resistant antibiotics - Chicago Tribune
https://www.chicagotribune.com/opinion/commentary/ct-opinion-antibiotic-resistant-infections-bacteria-20200727-v6su7usv5bgezkwvjvlqcg6vta-story.html
2019-02 Aradigm files for bankruptcy
2019-04 Achaogen files for bankruptcy
AMR Action Fund
Antibiotic resistance and pharmaceutical business models
Covid-19 and antimicrobial resistance
Cost of innovation making fight against superbugs near impossible - Opinion - MM&M - Medical Marketing and Media
https://www.mmm-online.com/home/opinion/cost-of-innovation-making-fight-against-superbugs-near-impossible/
2019-02 Aradigm files for bankruptcy
2019-04 Achaogen files for bankruptcy
2019-12 Melinta files for bankruptcy
DISARM Act model legislation
Tetraphase
Crisis Looms in Antibiotics as Drug Makers Go Bankrupt - The New York Times
https://www.nytimes.com/2019/12/25/health/antibiotics-new-resistance.html
2019-02 Aradigm files for bankruptcy
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
Articles in the New York Times
Biomedical Advanced Research and Development Authority (BARDA)
CARB-X
DISARM Act model legislation
Eravacycline
Plazomicin
Els Torreele: The search for new antibiotics—market based solutions are not the answer - The BMJ
https://blogs.bmj.com/bmj/2019/07/11/els-torreele-fixing-the-wrong-problem-in-the-search-for-new-antibiotics-market-based-solutions-are-not-the-answer/
2019-04 Achaogen files for bankruptcy
Failure Against “Nightmare Bacteria” a Chilling Commentary on Future of Antibiotics – “Much of Modern Medicine May Become Infeasible”
https://scitechdaily.com/failure-against-nightmare-bacteria-a-chilling-commentary-on-future-of-antibiotics-much-of-modern-medicine-may-become-infeasible/
2019-04 Achaogen files for bankruptcy
2019-10 University of Pittsburg study on new antibiotics for carbapenem-resistant Enterobacteriaceae
Fighting ‘superbugs’ in Massachusetts (Guest viewpoint) - masslive.com
https://www.masslive.com/opinion/2020/01/fighting-superbugs-in-massachusetts-guest-viewpoint.html
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
DISARM Act model legislation
Tetraphase
How Expert Societies Could Help the Economics of Antibiotics | American Council on Science and Health
https://www.acsh.org/news/2019/07/24/how-expert-societies-could-help-economics-antibiotics-14177
2019-04 Achaogen files for bankruptcy
Inside CARB-X, the Boston Fund on the Front Lines Fighting Antibiotic Resistance
https://www.americaninno.com/boston/inno-news-boston/inside-carb-x-the-boston-fund-on-the-front-lines-fighting-antibiotic-resistance/
2019-04 Achaogen files for bankruptcy
CARB-X
Is Antibiotic Development Now the Road Less Traveled?
https://www.contagionlive.com/contributor/saskia-v-popescu/2019/05/is-antibiotic-development-now-the-road-less-traveled
2019-04 Achaogen files for bankruptcy
Losing the War on Antibiotic-Resistant Infections Because of Market Forces | BioSpace
https://www.biospace.com/article/losing-the-war-on-antibiotic-resistant-infections-because-of-market-forces/
2019-04 Achaogen files for bankruptcy
New antibiotics are urgently needed, but economics stand in the way - MedCity News
https://medcitynews.com/2019/05/new-antibiotics-are-urgently-needed-but-economics-stand-in-the-way/
2019-04 Achaogen files for bankruptcy
Papers highlight challenges, solutions in developing antibiotics | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/papers-highlight-challenges-solutions-developing-antibiotics
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
Carbapenem-resistant Enterobacteriaceae (CRE)
Ceftazidime-avibactam
Meropenem-vaborbactam
Plazomicin
Reframing the antimicrobial resistance crisis | TheHill
https://thehill.com/opinion/healthcare/478488-reframing-the-antimicrobial-resistance-crisis
2019-04 Achaogen files for bankruptcy
2019-12 Melinta files for bankruptcy
The Radical Plan to Change How Antibiotics Get Developed | WIRED
https://www.wired.com/story/the-radical-plan-to-change-how-antibiotics-get-developed/
2019-04 Achaogen files for bankruptcy
Pharmaceutical makers, antibiotic resistance and the development of new drugs
UPDATED: UK courts antibiotic developers with ‘subscription-style’ incentive to combat superbug scourge – Endpoints News
https://endpts.com/uk-courts-antibiotic-developers-with-subscription-style-incentive-to-combat-superbug-scourge/
2019-04 Achaogen files for bankruptcy
2019-07 NHS to pilot a subscription approach to promote the development of new antibiotics
W.H.O. Warns That Pipeline for New Antibiotics Is Running Dry - The New York Times
https://www.nytimes.com/2020/01/17/health/antibiotics-resistance-new-drugs.html
2019-02 Aradigm files for bankruptcy
2019-04 Achaogen files for bankruptcy
2019-12 Melinta files for bankruptcy
2020-01 World Health Organization releases two reports on the antibiotics pipeline
Articles in the New York Times
Working to Fight AMR
World Health Organization and antimicrobial resistance
Who will pay the price for inaction on superbugs? - Pharmaphorum
https://pharmaphorum.com/r-d/views-analysis-r-d/who-will-pay-the-price-for-inaction-on-superbugs/
2019-04 Achaogen files for bankruptcy
Will Government Incentives Help Boost Antibiotic Development? Some Pharma Companies Think So | BioSpace
https://www.biospace.com/article/will-government-incentives-help-boost-antibiotic-development-some-pharma-companies-think-so/
2019-04 Achaogen files for bankruptcy
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Will Nonprofits Take Over Antibiotic Production? - Non Profit News | Nonprofit Quarterly
https://nonprofitquarterly.org/will-nonprofits-take-over-antibiotic-production/
2019-04 Achaogen files for bankruptcy
World AMR Congress: Fighting Anti-Microbial Resistance | BioSpace
https://www.biospace.com/article/world-amr-congress-fighting-anti-microbial-resistance/
2019-04 Achaogen files for bankruptcy
Antibiotic resistance and pharmaceutical business models
Plazomicin
Working to Fight AMR